Skip to main content

Alzheimer’s study could speed drug trials, expand data on progression

Seeking to put Alzheimer’s disease on the same footing as cancer and heart disease, health officials are embarking on a landmark initiative that regularly will scan the brains and analyze the bodily fluids of 800 people. With at least $60 million to spend over the next five years, the undertaking will involve 45 universities, including the University of Wisconsin-Madison.